DeviceClearance

PROCEDURE NO. 552/553 BILIRUBIN, TOTAL AND DIRECT— 510(k) K872197

Substantially Equivalent

Sigma Diagnostics, Inc.

FDA 510(k) clearance K872197 for PROCEDURE NO. 552/553 BILIRUBIN, TOTAL AND DIRECT, Substantially Equivalent on 1987-08-13. Applicant: Sigma Diagnostics, Inc..

Clearance details

Applicant
Sigma Diagnostics, Inc.
Product code
Code CIG
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
St. Louis, MO, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.